Here’s an overview of some of last week’s most interesting news, articles, interviews and videos:
Taking cybersecurity investments to the next levelIn this Help Net Security interview, the former Trident Capital leader offers insight into innovation in the cybersecurity market, M&A…
Source: news.google.com – Read more
Startup OMass Secures $310M to Advance Drug for Rare Endocrine Disorder
OMass’s molecule is vying to become an alternative to a Neurocrine Biosciences drug that is currently the only FDA-approved therapy for congenital adrenal hyperplasia. But
